Five year extension agreed for Wellcome/DBT India Alliance

This builds on a successful first 10 years for the India Alliance that has seen the alliance identify the best researchers and nurture them, build excellence in biomedical research, and help build and develop the Indian research ecosystem.

Mike Turner, Director of Science at Wellcome, said: “We’re delighted that the Cabinet of the Government of India has approved a new five-year phase of the Wellcome Trust/DBT India Alliance. Over the last 10 years, this partnership has supported the growth of Indian biomedical science, led to new international partnerships and helped develop the careers of researchers.

“We look forward to building on this work as the India Alliance now introduces three new initiatives which will fund collaborative research projects, clinical research centres, and clinical training.”

In its first phase The India Alliance was an equal partnership between the Department of Biotechnology (DBT), Government of India and Wellcome. This next stage will see the DBT increase its financial commitment to two times that of Wellcome.

The next five years will see the India Alliance increase its efforts and move into new areas that will build excellence in Indian Science and support researchers to drive policy and solve important health problems for India. 

Dr Shahid Jameel, CEO, India Alliance, said: “At India Alliance, it is a proud moment for us owing to the confidence reposed in us by the Government of India, DBT, and Wellcome Trust in approving the next phase with increased funding. This brings exciting opportunities, which we will use to create new benchmarks for research funding, engagement and ecosystem development.”